Centre for Psychiatry Research, Karolinska Institute Department of Clinical Neuroscience, Stockholm, Stockholm, Sweden
Liljeholmen University Primary Health Care Center, Region Stockholm, Academic Primary Care Centre, Stockholm, Stockholm, Sweden.
BMJ Open. 2024 Apr 3;14(4):e075796. doi: 10.1136/bmjopen-2023-075796.
Depression and anxiety are major public health problems. This study evaluated the effects of internet-delivered transdiagnostic psychological treatments for individuals with depression, anxiety, or both.
Systematic review with meta-analysis.
Medline (Ovid), Cochrane Library (Wiley), the Web of Science Core Collection (Clarivate), and PsycInfo (EBSCO) were searched on 24 May 2021, with an update on 6 February 2023.
Randomised controlled trials of internet-delivered transdiagnostic psychological treatments, open to both participants with primary depression and participants with primary anxiety. This review concerned all treatment frameworks, both guided and unguided formats and all age groups.
In random-effects meta-analysis, we estimated pooled effects on depression symptoms and anxiety in terms of Hedges' with 95% CIs. Absolute and relative heterogeneity was quantified as the τ and .
We included 57 trials with 21 795 participants. Nine trials (16%) recruited exclusively from routine care, and three (5%) delivered treatment via video. For adults, large within-group reductions were seen in depression (=0.90; 95% CI 0.81 to 0.99) and anxiety (=0.87; 95% CI 0.78 to 0.96). Compared with rudimentary passive controls, the added effects were moderate (depression: =0.52; 95% CI 0.42 to 0.63; anxiety: =0.45; 95% CI 0.34 to 0.56) and larger in trials that required all participants to meet full diagnostic criteria for depression or an anxiety disorder. Compared with attention/engagement controls, the added effects were small (depression: =0.30; 95% CI 0.07 to 0.53; anxiety: =0.21; 95% CI 0.01 to 0.42). Heterogeneity was substantial, and the certainty of the evidence was very low. Two trials concerned adolescents and reported mixed results. One trial concerned older adults and reported promising results.
Internet-delivered transdiagnostic treatments for depression and anxiety show small-to-moderate added effects, varying by control condition. Research is needed regarding routine care, the video format, children and adolescents and older adults.
CRD42021243172.
抑郁和焦虑是主要的公共卫生问题。本研究评估了针对抑郁、焦虑或两者共病的互联网传递的跨诊断心理治疗的效果。
系统评价和荟萃分析。
2021 年 5 月 24 日在 Medline(Ovid)、Cochrane 图书馆(Wiley)、Web of Science 核心合集(Clarivate)和 PsycInfo(EBSCO)进行检索,2023 年 2 月 6 日进行更新。
互联网传递的跨诊断心理治疗的随机对照试验,对原发性抑郁和原发性焦虑的参与者均开放。本综述涉及所有治疗框架,包括有指导和无指导的格式以及所有年龄组。
在随机效应荟萃分析中,我们根据 Hedges' 以 95%CI 估计了抑郁症状和焦虑的汇总效应。以 τ 和 量化绝对和相对异质性。
我们纳入了 57 项试验,涉及 21795 名参与者。9 项试验(16%)仅从常规护理中招募参与者,3 项试验(5%)通过视频提供治疗。对于成年人,抑郁(=0.90;95%CI 0.81 至 0.99)和焦虑(=0.87;95%CI 0.78 至 0.96)的组内降幅较大。与基本的被动对照相比,附加效应适度(抑郁:=0.52;95%CI 0.42 至 0.63;焦虑:=0.45;95%CI 0.34 至 0.56),在要求所有参与者都符合抑郁或焦虑障碍的完整诊断标准的试验中更大。与注意力/参与对照相比,附加效应较小(抑郁:=0.30;95%CI 0.07 至 0.53;焦虑:=0.21;95%CI 0.01 至 0.42)。异质性很大,证据的确定性非常低。两项试验涉及青少年,报告了混合结果。一项试验涉及老年人,报告了有希望的结果。
针对抑郁和焦虑的互联网传递的跨诊断治疗显示出较小到中等的附加效果,具体取决于对照条件。需要研究常规护理、视频格式、儿童和青少年以及老年人。
PROSPERO 注册号:CRD42021243172。